The 8 most recent market catalysts affecting $PAGP, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 6, 2026
Corporate Catalyst
Bullish
Impact 92
Plains GP Holdings, L.P. Reports Third-Quarter 2026 Financial Results
Plains GP Holdings (PAGP) and Plains All American Pipeline (PAA) reported robust Q3 2026 financial results, with PAA achieving $711 million in Adjusted EBITDA. This strong performa…
Oct 9, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Maintains Buy on Plains GP Holdings, Raises Price Target to $30
UBS analyst Manav Gupta maintained a 'Buy' rating on Plains GP Holdings (PAGP) and raised the price target from $26 to $30. This action signals increased confidence from a major fi…
Sep 21, 2026
Corporate Catalyst
Bullish
Impact 55
Mizuho Maintains Outperform on Plains GP Holdings, Raises Price Target to $30
Mizuho analyst Gabriel Moreen has maintained an 'Outperform' rating for Plains GP Holdings (PAGP) and raised the price target from $27 to $30. This analyst upgrade signals increase…
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 75
Plains GP Holdings shares are trading higher after the company reported better-than-expected Q2 sales results.
This headline is a significant corporate catalyst for Plains GP Holdings (PAGP) and its parent company, Plains All American Pipeline (PAA). Better-than-expected sales indicate stro…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 75
Plains GP Holdings shares are trading higher after the company reported better-than-expected Q2 sales results.
This headline represents a significant corporate catalyst for Plains GP Holdings (PAGP) and its related entity, Plains All American Pipeline (PAA). Better-than-expected sales indic…
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 92
Plains GP Holdings Q2 EPS $(0.37) Misses $0.39 Estimate, Sales $17.693B Beat $12.865B Estimate
Plains GP Holdings (PAGP) delivered a mixed Q2 report, with a substantial earnings per share miss of 194.87% compared to analyst estimates, indicating potential profitability chall…
Jul 16, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Underweight on Plains GP Holdings, Raises Price Target to $23
Barclays analyst Theresa Chen maintained an 'Underweight' rating on Plains GP Holdings (PAGP) but raised the price target from $21 to $23. This indicates that while the analyst see…
Jul 15, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Securities Maintains Buy on Plains GP Holdings, Raises Price Target to $25
Truist Securities analyst Gabe Daoud has maintained a 'Buy' rating on Plains GP Holdings (PAGP) and raised the price target from $23 to $25. This action indicates a continued posit…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.